Chunping Gu
Impact in
- Physiology top 10%
- Pain Mechanisms and Treatments
-
- Gastrointestinal motility and disorders
Papers in
-
- Cell death mechanisms and regulation 2
- Oncology 7
- Cancer-related Molecular Pathways 3
- Co-authors
- Shuwen Liu (13 shared papers)Le Yu (11 shared papers)Elie D. Al–Chaer (4 shared papers)Yi Kong (4 shared papers)Zhitao Zhou (2 shared papers)Lili Shi (2 shared papers)Jing Wang (1 shared paper)Carl Y. Saab (1 shared paper)
- Journals
- Pharmacology (2 papers)Cancer Letters (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Journal of Cellular Biochemistry (1 paper)Acta Pharmacologica Sinica (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Chunping Gu
24 papers receiving 367 citations
Peers
Comparison fields: 5 of 79
- Physiology 28
- Gastroenterology 22
- Cancer Research 49
- Pharmacology 51
- Epidemiology 93
Countries citing papers authored by Chunping Gu
This map shows the geographic impact of Chunping Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunping Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunping Gu more than expected).
Fields of papers citing papers by Chunping Gu
This network shows the impact of papers produced by Chunping Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunping Gu. The network helps show where Chunping Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chunping Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 99 | |
| 2 | 2013 | 44 | |
| 3 | 2006 | 41 | |
| 4 | 2016 | 30 | |
| 5 | 2008 | 23 | |
| 6 | 2014 | 23 | |
| 7 | 2012 | 21 | |
| 8 | 2008 | 20 | |
| 9 | 2017 | 20 | |
| 10 | 2015 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2014 | 5 | |
| 14 | 2013 | 5 | |
| 15 | 2014 | 5 | |
| 16 | [Synergistic anti-tumor effect of obatoclax and MG-132 in esophageal cancer cell line CaES-17]. | 2016 | 4 |
| 17 | 2018 | 3 | |
| 18 | 2018 | 2 | |
| 19 | [Celecoxib antagonizes the cytotoxic effect of carboplatin in human esophageal cancer cells]. | 2014 | 2 |
| 20 | 2024 | 1 |
About Chunping Gu
Chunping Gu is a scholar working on Molecular Biology, Oncology, Epidemiology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 24 papers that have together received 373 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Autophagy in Disease and Therapy (3 papers), Inflammatory mediators and NSAID effects (3 papers), Pediatric Pain Management Techniques (2 papers), Pain Mechanisms and Treatments (2 papers), NF-κB Signaling Pathways (2 papers), Cell death mechanisms and regulation (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Physiology (28 citations), Gastroenterology (22 citations), Cancer Research (49 citations), Pharmacology (51 citations) and Epidemiology (93 citations). Chunping Gu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shuwen Liu, Le Yu, Elie D. Al–Chaer, Yi Kong, Zhitao Zhou, Lili Shi, Jing Wang, Carl Y. Saab, Abdallah Hayar and Xiaojuan Li. Their work appears in journals such as Pharmacology, Cancer Letters, Bioorganic & Medicinal Chemistry, Journal of Cellular Biochemistry and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.